Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 11, 2007 - Issue 6
Submit an article Journal homepage
306
Views
49
CrossRef citations to date
0
Altmetric
Review

The therapeutic uses of chromatin-modifying agents

Antonello Mai Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Studi Farmaceutici, Università di Roma ‘La Sapienza’, Piazzale Aldo Moro 5, I-00185 Roma, Italy. [email protected]
Pages 835-851 | Published online: 15 May 2007

Citations (49)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Brian R Keppler & Trevor K Archer. (2008) Chromatin-modifying enzymes as therapeutic targets – Part 1. Expert Opinion on Therapeutic Targets 12:10, pages 1301-1312.
Read now
Andrew D Rowan, Gary J Litherland, Wang Hui & Jennifer M Milner. (2008) Metalloproteases as potential therapeutic targets in arthritis treatment. Expert Opinion on Therapeutic Targets 12:1, pages 1-18.
Read now

Articles from other publishers (47)

Mascha Mayer, Alexander Berger, Christian Leischner, Olga Renner, Markus Burkard, Alexander Böcker, Seema Noor, Timo Weiland, Thomas S. Weiss, Christian Busch, Ulrich M. Lauer, Stephan C. Bischoff & Sascha Venturelli. (2022) Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular Carcinoma. Pharmaceuticals 15:4, pages 438.
Crossref
Olga Renner, Mascha Mayer, Christian Leischner, Markus Burkard, Alexander Berger, Ulrich M. Lauer, Sascha Venturelli & Stephan C. Bischoff. (2022) Systematic Review of Gossypol/AT-101 in Cancer Clinical Trials. Pharmaceuticals 15:2, pages 144.
Crossref
Mohammed A. Al-Hamamah, Moureq R. Alotaibi, Sheikh F. Ahmad, Mushtaq A. Ansari, Mohamed S.M. Attia, Ahmed Nadeem, Saleh A. Bakheet, Homood M. As Sobeai & Sabry M. Attia. (2019) Genetic and epigenetic alterations induced by the small-molecule panobinostat: A mechanistic study at the chromosome and gene levels. DNA Repair 78, pages 70-80.
Crossref
Marilena Celano, Catia Mio, Marialuisa Sponziello, Antonella Verrienti, Stefania Bulotta, Cosimo Durante, Giuseppe Damante & Diego Russo. (2018) Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer. Molecular and Cellular Endocrinology 469, pages 38-47.
Crossref
Amir Hosseini & Saverio Minucci. 2018. Epigenetics in Human Disease. Epigenetics in Human Disease 141 217 .
Walter H. Moos, Eleni Maneta, Carl A. Pinkert, Michael H. Irwin, Michelle E. Hoffman, Douglas V. Faller & Kosta Steliou. (2016) Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia. Drug Development Research 77:2, pages 53-72.
Crossref
Kosta Steliou, Douglas V. Faller, Carl A. Pinkert, Michael H. Irwin & Walter H. Moos. (2015) Bioprotective Carnitinoids: Lipoic Acid, Butyrate, and Mitochondria-Targeting to Treat Radiation Injury: Mitochondrial Drugs Come of Age. Drug Development Research 76:4, pages 167-175.
Crossref
Antonella Di Costanzo, Nunzio Del Gaudio, Antimo Migliaccio & Lucia Altucci. (2014) Epigenetic drugs against cancer: an evolving landscape. Archives of Toxicology 88:9, pages 1651-1668.
Crossref
Peter J. van den Elsen, Marja C.J.A. van Eggermond, Fabiola Puentes, Paul van der Valk, David Baker & Sandra Amor. (2014) The epigenetics of multiple sclerosis and other related disorders. Multiple Sclerosis and Related Disorders 3:2, pages 163-175.
Crossref
Soraya E Gutierrez & Francisco A Romero-Oliva. (2013) Epigenetic changes: a common theme in acute myelogenous leukemogenesis. Journal of Hematology & Oncology 6:1.
Crossref
Francesco Paneni, Massimo Volpe, Thomas Felix Lüscher & Francesco Cosentino. (2013) SIRT1, p66Shc, and Set7/9 in Vascular Hyperglycemic Memory. Diabetes 62:6, pages 1800-1807.
Crossref
Alexander Berger, Sascha Venturelli, Mascha Kallnischkies, Alexander Böcker, Christian Busch, Timo Weiland, Seema Noor, Christian Leischner, Thomas S. Weiss, Ulrich M. Lauer, Stephan C. Bischoff & Michael Bitzer. (2013) Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases. The Journal of Nutritional Biochemistry 24:6, pages 977-985.
Crossref
G Karthikeyan, Maneesh Paul-Satyaseela, Nachiappan Dhatchana Moorthy, Radha Gopalaswamy & Shridhar Narayanan. (2014) Functional characterization of Candida albicans Hos2 histone deacetylase. F1000Research 2, pages 238.
Crossref
G Karthikeyan, Maneesh Paul-Satyaseela, Nachiappan Dhatchana Moorthy, Radha Gopalaswamy & Shridhar Narayanan. (2013) Functional characterization of Candida albicans Hos2 histone deacetylase. F1000Research 2, pages 238.
Crossref
Viktor Brabec, Darren M. Griffith, Anna Kisova, Hana Kostrhunova, Lenka Zerzankova, Celine J. Marmion & Jana Kasparkova. (2012) Valuable Insight into the Anticancer Activity of the Platinum-Histone Deacetylase Inhibitor Conjugate, cis -[Pt(NH 3 ) 2 malSAHA –2H )] . Molecular Pharmaceutics 9:7, pages 1990-1999.
Crossref
V. Le Douce, A. Janossy, H. Hallay, S. Ali, R. Riclet, O. Rohr & C. Schwartz. (2012) Achieving a cure for HIV infection: do we have reasons to be optimistic?. Journal of Antimicrobial Chemotherapy 67:5, pages 1063-1074.
Crossref
Ciro Mercurio, Simon Plyte & Saverio Minucci. 2012. Epigenetics in Human Disease. Epigenetics in Human Disease 53 87 .
Christina M. Lill, Rudolph E. Tanzi & Lars Bertram. 2012. Basic Neurochemistry. Basic Neurochemistry 719 736 .
Eleni Pontiki & Dimitra Hadjipavlou-Litina. (2012) Histone deacetylase inhibitors (HDACIs). Structure-activity relationships: history and new QSAR perspectives. Medicinal Research Reviews 32:1, pages 1-165.
Crossref
Richard M. Eglen & Terry Reisine. (2011) Screening for Compounds That Modulate Epigenetic Regulation of the Transcriptome: An Overview. SLAS Discovery 16:10, pages 1137-1152.
Crossref
C. Napoli, T. Infante & A. Casamassimi. (2011) Maternal-foetal epigenetic interactions in the beginning of cardiovascular damage. Cardiovascular Research 92:3, pages 367-374.
Crossref
Kristina Keller & Manfred Jung. (2011) Lesezeichen im Buch des Lebens. Nachrichten aus der Chemie 59:9, pages 822-827.
Crossref
Fabrizio Dal Piaz, Antonio Vassallo, Osmany Cuesta Rubio, Sabrina Castellano, Gianluca Sbardella & Nunziatina De Tommasi. (2011) Chemical biology of Histone acetyltransferase natural compounds modulators. Molecular Diversity 15:2, pages 401-416.
Crossref
Sergio Valente, Maria Tardugno, Mariarosaria Conte, Roberto Cirilli, Andrea Perrone, Rino Ragno, Silvia Simeoni, Anna Tramontano, Silvio Massa, Angela Nebbioso, Marco Miceli, Gianluigi Franci, Gerald Brosch, Lucia Altucci & Antonello Mai. (2011) Novel Cinnamyl Hydroxyamides and 2-Aminoanilides as Histone Deacetylase Inhibitors: Apoptotic Induction and Cytodifferentiation Activity. ChemMedChem 6:4, pages 698-712.
Crossref
Claudio Napoli. (2011) Developmental Mechanisms Involved in the Primary Prevention of Atherosclerosis and Cardiovascular Disease. Current Atherosclerosis Reports 13:2, pages 170-175.
Crossref
Wayne W. Hancock. 2011. Histone Deacetylases: the Biology and Clinical Implication. Histone Deacetylases: the Biology and Clinical Implication 103 123 .
Antonello Mai. 2009. PATAI'S Chemistry of Functional Groups. PATAI'S Chemistry of Functional Groups.
Mohammed Arif, Parijat Senapati, Jayasha Shandilya & Tapas K. Kundu. (2010) Protein lysine acetylation in cellular function and its role in cancer manifestation. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1799:10-12, pages 702-716.
Crossref
Margarete von Wantoch Rekowski & Athanassios Giannis. (2010) Histone acetylation modulation by small molecules: A chemical approach. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1799:10-12, pages 760-767.
Crossref
Ciro Mercurio, Saverio Minucci & Pier Giuseppe Pelicci. (2010) Histone deacetylases and epigenetic therapies of hematological malignancies. Pharmacological Research 62:1, pages 18-34.
Crossref
Rutger J. Wierda, Sacha B. Geutskens, J. Wouter Jukema, Paul H.A. Quax & Peter J. van den Elsen. (2010) Epigenetics in atherosclerosis and inflammation. Journal of Cellular and Molecular Medicine 14:6a, pages 1225-1240.
Crossref
Fabrizio Dal Piaz, Alessandra Tosco, Daniela Eletto, Anna L. Piccinelli, Ornella Moltedo, Silvia Franceschelli, Gianluca Sbardella, Paolo Remondelli, Luca Rastrelli, Loredana Vesci, Claudio Pisano & Nunziatina De Tommasi. (2010) The Identification of a Novel Natural Activator of p300 Histone Acetyltranferase Provides New Insights into the Modulation Mechanism of this Enzyme. ChemBioChem 11:6, pages 818-827.
Crossref
Antonello Mai. (2010) Small-molecule chromatin-modifying agents: therapeutic applications. Epigenomics 2:2, pages 307-324.
Crossref
Thomas Cherrier, Valentin Le Douce, Lætitia Redel, Céline Marban, Dominique Aunis, Olivier Rohr & Christian Schwartz. (2010) Un virus tapi dans l’ombre : les bases moléculaires de la latence du VIH-1. médecine/sciences 26:3, pages 291-296.
Crossref
Pritika Narayan & Mike Dragunow. (2010) Pharmacology of epigenetics in brain disorders. British Journal of Pharmacology 159:2, pages 285-303.
Crossref
Darren M Hutt, David Herman, Ana P C Rodrigues, Sabrina Noel, Joseph M Pilewski, Jeanne Matteson, Ben Hoch, Wendy Kellner, Jeffery W Kelly, Andre Schmidt, Philip J Thomas, Yoshihiro Matsumura, William R Skach, Martina Gentzsch, John R Riordan, Eric J Sorscher, Tsukasa Okiyoneda, John R YatesIIIIII, Gergely L Lukacs, Raymond A Frizzell, Gerard Manning, Joel M Gottesfeld & William E Balch. (2009) Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nature Chemical Biology 6:1, pages 25-33.
Crossref
Andrea Savarino, Antonello Mai, Sandro Norelli, Sary El Daker, Sergio Valente, Dante Rotili, Lucia Altucci, Anna Teresa Palamara & Enrico Garaci. (2009) "Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence. Retrovirology 6:1.
Crossref
Laetitia Redel, Valentin Le Douce, Thomas Cherrier, Céline Marban, Andrea Janossy, Dominique Aunis, Carine Van Lint, Olivier Rohr & Christian Schwartz. (2010) HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes. Journal of Leukocyte Biology 87:4, pages 575-588.
Crossref
Margarete von Wantoch Rekowski & Athanassios Giannis. 2009. Epigenetic Targets in Drug Discovery. Epigenetic Targets in Drug Discovery 243 250 .
Steven Christopher Smith & Dan Theodorescu. (2009) Learning therapeutic lessons from metastasis suppressor proteins. Nature Reviews Cancer 9:4, pages 253-264.
Crossref
Rachel Codd, Najwa Braich, Joe Liu, Cho Zin Soe & Amalie A.H. Pakchung. (2009) Zn(II)-dependent histone deacetylase inhibitors: Suberoylanilide hydroxamic acid and trichostatin A. The International Journal of Biochemistry & Cell Biology 41:4, pages 736-739.
Crossref
Stephanie Spange, Tobias Wagner, Thorsten Heinzel & Oliver H. Krämer. (2009) Acetylation of non-histone proteins modulates cellular signalling at multiple levels. The International Journal of Biochemistry & Cell Biology 41:1, pages 185-198.
Crossref
Hans Leemhuis, Karl P. Nightingale & Florian Hollfelder. (2008) Directed evolution of a histone acetyltransferase – enhancing thermostability, whilst maintaining catalytic activity and substrate specificity. The FEBS Journal 275:22, pages 5635-5647.
Crossref
B. Ruthrotha Selvi, Dinesh Jagadeesan, B. S. Suma, G. Nagashankar, M. Arif, K. Balasubramanyam, M. Eswaramoorthy & Tapas K. Kundu. (2008) Intrinsically Fluorescent Carbon Nanospheres as a Nuclear Targeting Vector: Delivery of Membrane-Impermeable Molecule to Modulate Gene Expression In Vivo. Nano Letters 8:10, pages 3182-3188.
Crossref
Fei Chu, Pauline Chou, Bernard L. Mirkin, Shaker A. Mousa & Abdelhadi Rebbaa. (2008) Cellular conditioning with trichostatin A enhances the anti-stress response through up-regulation of HDAC4 and down-regulation of the IGF/Akt pathway. Aging Cell 7:4, pages 516-525.
Crossref
Antonello MaiDonghang ChengMark T. BedfordSergio ValenteAngela NebbiosoAndrea PerroneGerald BroschGianluca SbardellaFloriana De BellisMarco MiceliLucia Altucci. (2008) Epigenetic Multiple Ligands: Mixed Histone/Protein Methyltransferase, Acetyltransferase, and Class III Deacetylase (Sirtuin) Inhibitors. Journal of Medicinal Chemistry 51:7, pages 2279-2290.
Crossref
Antonello Mai, Andrea Perrone, Angela Nebbioso, Dante Rotili, Sergio Valente, Maria Tardugno, Silvio Massa, Floriana De Bellis & Lucia Altucci. (2008) Novel uracil-based 2-aminoanilide and 2-aminoanilide-like derivatives: Histone deacetylase inhibition and in-cell activities. Bioorganic & Medicinal Chemistry Letters 18:8, pages 2530-2535.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.